‏إظهار الرسائل ذات التسميات Tobacco. إظهار كافة الرسائل
‏إظهار الرسائل ذات التسميات Tobacco. إظهار كافة الرسائل

New research reveals only nine users of safer nicotine products for every 100 smokers worldwide

Source: GSTHR 2020. The figures show the urgency of scaling up tobacco harm reduction in the fight against smoking-related death and disease. (PRNewsfoto/Knowledge Action Change (KAC))

Global tobacco control's hostility to tobacco harm reduction is risking the health and lives of millions with LMIC worst hit, say experts


NEW DELHI , Nov. 6, 2020 /PRNewswire/ -- Burning Issues: The Global State of Tobacco Harm Reduction (GSTHR) 2020 , the latest in a landmark report series from UK-based public health agency Knowledge Action Change (KAC) was launched on 4th November, at an open access online event . Tobacco harm reduction supports people to quit smoking by using safer nicotine products (SNP) including vaping devices (e-cigarettes), heated tobacco products (HTP) and pasteurised oral snus, improving health and reducing deaths by enabling people to use nicotine without the smoke that causes disease.

In a world first, the authors of Burning Issues revealed an estimate for the total global number of users of safer nicotine products, showing that there is an urgent need to scale up tobacco harm reduction if its full public health potential is to be realised:

There are only nine SNP users for every 100 smokers globally, mainly in high income countries; Overall, 98 million people are estimated to use safer nicotine products worldwide; Of those, 68 million are vapers , with the largest vaping populations in the US, China , the Russian Federation , the UK, France , Japan , Germany and Mexico ; 20 million are HTP users ; with most HTP users in Japan , where cigarette sales have dropped by 32% since 2016 when HTP were launched; 10 million are US smokeless or snus users. Official monitoring of SNP use is currently limited - yet is essential to understand their impact and potential in tackling smoking-related death and disease. Nevertheless, these numbers demonstrate the scale of consumer uptake and acceptance of these products as alternatives to combustible tobacco, which kills half its users.

Meanwhile, the global public health crisis of smoking is ongoing and deadly. 1.1bn people smoke worldwide, a figure that has remained unchanged for two decades despite billions spent by governments and the World Health Organization (WHO) on tobacco control. 80% of the world's smokers live in low and middle-income countries (LMIC), and eight million people die due to smoking-related disease every year. The WHO estimates that one billion people will die of smoking-related disease by 2100.

The urgent need to find new approaches is clear, especially in LMIC, where tobacco control measures are often poorly or partially implemented, smoking rates are high or plateauing, population growth is increasing the number of smokers, and health systems are least able to treat smoking-related disease effectively or offer smokers support to quit.

Since SNP have become available, accessible and affordable in countries such as Japan , the UK and Iceland , existing declines in smoking rates have accelerated. Yet despite the emergence of products that are demonstrably safer than combustible cigarettes, proven to be effective in smoking cessation and attractive to adult consumers who are quitting and switching in their millions, tobacco harm reduction continues to be seen by many in global health and tobacco control as a threat, not a public health opportunity.

Innovation rejected and tobacco policy distorted

Burning Issues identifies the extent to which tobacco control policy both at the WHO and in individual nation states is being influenced by billions of dollars from US foundations that are actively supporting campaigns against tobacco harm reduction. In countries such as the UK and US where tobacco harm reduction already has a foothold, misinformation and manufactured moral panics about SNP's risks are impacting on confidence – discouraging smokers from making the switch.

Furthermore, governments in LMIC are being encouraged to ban SNP in the name of tobacco control, while the sale of tobacco continues unchecked. Rising concern over the influence of these actors was echoed in the Philippines House of Representatives a few weeks ago, with calls for a congressional inquiry into the Filipino Food and Drugs Administration's acceptance of funding from US-based anti-vaping groups.

Major new data mapping project demonstrates illogical approach

Launched in tandem with the report is GSTHR's major live data mapping project , which documents regulatory responses to SNP with live updates to over 200 regional and country profiles. The free-to-access resource shows that with the support of global tobacco control, 36 countries have banned vaping devices/e cigarettes, 39 have banned ban snus and 13 countries have banned HTP. By contrast, just one country (Bhutan ) has enacted a ban on the sale of combustible tobacco, which is currently lifted due to COVID-19.

At the launch, expert speakers call for change

The Open access online launch, co-hosted by KAC in London and Lilongwe -based NGO THR Malawi, heard from a range of speakers including Emeritus Professor at Imperial College London and KAC Director Professor Gerry Stimson , Burning Issues Executive Editor Harry Shapiro , and leading neuropsychopharmacology's and drug policy expert Professor David Nutt .

Professor Gerry Stimson , Emeritus Professor at Imperial College London and KAC Director , said "This is a decisive moment for the future health of 1.1 billion smokers around the world, who deserve better than the status quo. Policymakers engaged in the current European Commission Tobacco Products Directive revision and next year's WHO FCTC Conference of the Parties must consider the evidence for tobacco harm reduction's role, listen to consumers, and deliver policies that genuinely focus on reducing the global toll of smoking- related disease and deaths as quickly as possible. If integrated into tobacco control, harm reduction could be a gamechanger in the battle against non-communicable disease."

Guest speaker Professor David Nutt , founder of DrugScience and Edmund J. Safra Professor of Neuropsychopharmacology at Imperial College London said: "My work leading a multicriteria decision analysis on the harms of different nicotine products back in 2013 contributed to the understanding that e-cigarettes are around 95 per cent less harmful than cigarettes. Yet many so-called 'experts' rebuff scientific evidence on vaping or snus safety and deny relative harm data, while insulting and libeling scientists like myself. To reject the opportunity of tobacco harm reduction is, perhaps, the worst example of scientific denial since the Catholic Church banned the works of Copernicus in 1616."

Harry Shapiro , Executive Editor of Burning Issues , said: "Our data shows that, worldwide, millions of people are choosing to improve their own health by switching from combustible tobacco. But this needs to scale up, fast. Tobacco harm reduction should become a genuine consumer-led public health success. But instead, we are seeing the start of a war on nicotine."

Samrat Chowdhery , President of The International Network of Nicotine Consumer  Organizations , Director of the Association of Vapers India , and vaping consumer said, "Given that over 80 per cent of tobacco users are in low- and middle-income countries with meagre means to deal with tobacco-related consequences, the focus ought to be unwaveringly on harm prevention, by allowing people to exercise the choice of avoiding death and disease by switching to affordable and accessible risk-reduced alternatives."

About

The GSTHR is a project run by Knowledge∙Action∙Change (KAC) , a company dedicated to the promotion of harm reduction to improve health, and produced with the help of a grant from the Foundation for a Smoke-Free World  Inc., an independent, US nonprofit 501(c)(3) which, under US law, must operate independently of its donors. All materials and reports produced by KAC under the Global State of Tobacco Harm Reduction project are, under the terms of the grant agreement, editorially independent of the Foundation. The contents, selection and presentation of facts, as well as any opinions expressed herein are the sole responsibility of the authors and under no circumstances shall be regarded as reflecting the positions of the Foundation for a Smoke-Free World, Inc.

Policy reforms needed to combat India's tobacco crisis: Global report

NEW DELHI , Nov. 6, 2020 /PRNewswire/ -- Speaking at the UK launch of a global report, tobacco harm reduction advocate and Director of Association of Vapers India (AVI), Samrat Chowdhery, said evidence-led policy reforms lead to better outcomes than bans in helping reduce deaths and disease from tobacco use.

The biennial report, Burning Issues: The Global State of Tobacco Harm Reduction (GSTHR) , published by UK-based public health agency Knowledge Action Change, finds that currently there are nine safer nicotine products (SNPs) users for every 100 smokers globally, most of whom live in high-income countries.

The report states that overall 98 million people are estimated to use SNPs worldwide. Of those, 68 million are vapers, with the largest vaping populations in the US, China , the Russian Federation , the UK, France , Japan , Germany and Mexico . The rest are users of snus, a low-risk smokeless tobacco variant popular in Scandinavian countries, and new heated tobacco products which deliver nicotine in cigarette-like form but without combustion.

Talking about the hurdles to wider adoption of SNPs, Chowdhery, who is president of global consumer body International Network of Nicotine Consumer Organisations (INNCO) and director of Association of Vapers India (AVI), said, "The report finds that 36 nations have banned low-risk alternatives, and most of them, barring a few outlier western nations, are low- and middle-income countries (LMICs) - a large number are in Latin America , many in the Middle East , some in Africa and a rising number in Asia ."

He said this is particularly concerning as a majority of smokers, almost 80% of over a billion worldwide, live in developing nations and they bear the largest tobacco health burden as a majority of the 8 million annual tobacco-related deaths are in these countries.

"These are also nations where access to public healthcare is poor, where smokers are least able to deal with the consequences of tobacco use such as getting treatment for medical conditions, which makes harm prevention even more vital," he said.

The INNCO president said increasing barriers to tobacco harm reduction ultimately serves to perpetuate smoking. "It hurts the health of the country, but also causes huge financial loss as tobacco-related mortality and morbidity costs rise, and by decimating an industry which could create jobs and revenue while improving the health of tobacco users."

"But the tide is turning and science is slowly but steadily winning over ideology," Chowdhery said. "Since the last edition of the GSTHR report in 2018, four countries [including India ] have banned THR alternatives while 22 nations from various regions of the world have either reversed bans or put in place formal regulations allowing their use," the AVI director said.

The India section of the report states policy reforms hold great prominence in the Indian context as it has the second-highest number of smokers globally, is a world leader in tobacco production, and has yet banned safer alternatives such as vaping and heated tobacco products.

One can also access the complete report here https://gsthr.org/resources/item/burning-issues-global-state-tobacco-harm-reduction-2020

About Association of Vapers India (AVI)

AVI is a not-for-profit organisation that defends the right of tobacco users to harm reduction.

Metaform Ventures Invests $2 Mn for Innovation in Tobacco Cessation & Harm Reduction in India

Metaform Ventures, led by Nilesh Jain, has committed to invest 2 Million USD in its India Center of Excellence, to conduct research on tobacco cessation & harm reduction, with focus on smokeless tobacco (SLT) products like jarda, ghutka, khaini, etc.

The objective is to provide hard empirical data and evidence to encourage new harm reduction tools, cessation techniques and products for a tobacco-free India. Smokeless Tobacco use accounts for 90% of oral cancers in India or a total of about 300,000 deaths a year. Studies suggest that regular users have a significantly overall higher death rate compared to non-users, and experience increased risks for low birth weight and stillbirths in children of women who use SLT during pregnancy. They also increase risks of tuberculosis (TB) and heart disease.

“Innovative thinking & profound changes within this sector can contribute significantly to public health. Leading new research, supported by government-led policy interventions, can help deploy technology options to reduce risks and transform core SLT products”, Nilesh Jain, “This harm reduction research program complemented by efforts to stimulate innovation in the cessation market can make toxic SLT history and in the process save hundreds of thousands of lives”.

With an objective to perform the characterization of Harmful and Potentially Harmful Constituents in Indian smokeless tobacco products, the project is to test several smokeless tobacco products across India. The data generated through this research will be useful for regulators and product innovators, & will help create capacity for independent research in India. Secondly, provided users with more options to choose from, thereby motivating them to move towards safer options, & reduced harm.

This highlights new research data to enable clinicians, regulators, and researchers with valuable information for considering the potential health effects that may result from the use of Indian SLT products and evaluate other harm reduction efforts via cessation techniques or THR products like SNUS.

“Our approach is very simple – to generate robust, credible data that will not only fill the current gap in research but also spur interest across the research community to become proactive in setting up lab testing infrastructure for Indian SLT product characterization and building research capacity. This focus on HPHC SLT characterization would not only massively improve the innovation of cost-effective SLTs but also help researchers to reduce some of the highest oral cancer death rates and tobacco-related disability rates.”, Nilesh Jain

Metaform Ventures, led by an angel investor and serial entrepreneur Nilesh Jain is an investment fund based out of Silicon Valley, California. Most recently, the fund had backed Clinivantage Healthcare, HeyDeeDee, Xplorabox, Log9 Materials and Picostone.

 

Market Reports

Market Report & Surveys
IndianWeb2.com © all rights reserved